AccurKardia vs Eko Health (2026)
Both use cleared machine learning to find heart problems, at different moments of care. AccurKardia works on monitoring data: AccurECG interprets ambulatory ECG recordings beat by beat across 13 rhythm classes, taking recordings from other makers' devices, and it holds two FDA 510(k) clearances. Eko Health works in the exam room. Its digital stethoscopes record heart sounds and a single lead ECG, and cleared models flag structural murmurs, atrial fibrillation and low ejection fraction. Clinicians can subscribe to Eko+, and health systems license SENSORA, which lets medical assistants and nurses capture at intake with a clinician reading afterwards. Choose AccurKardia to read days of monitoring data from any device; choose Eko to screen at the point of care, on Eko's own hardware.
- Interpretation of ambulatory recordings from other makers' patches and Holter monitors.
- Beat by beat analysis across 13 rhythm classes.
- Two FDA 510(k) clearances, the latest in December 2025.
- Digital stethoscopes that record heart sounds and a single lead ECG during a routine exam.
- FDA cleared detection of structural murmurs, atrial fibrillation and low ejection fraction.
- A published clinician price of $119.99 a year for Eko+, with SENSORA quoted for health systems.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. AccurKardia and Eko Health are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | AccurKardia | Eko Health |
|---|---|---|
| Primary category | Diagnostics & Genomics | Diagnostics & Genomics |
| Founded | 2019 | 2013 |
| Headquarters | New York, New York, United States | Emeryville, California |
| Website | accurkardia.com | ekohealth.com |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
Eko Health
-
Product / capability
Eko launched CORE 300, an FDA cleared stethoscope whose single chestpiece twists between traditional listening and Cardiac, Pulmonary and All Purpose digital modes, with up to 35 times amplification, active noise cancellation and an on device heart rate display.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
AccurKardia makes AccurECG, cloud based software for automated interpretation of ambulatory ECG recordings, sold to cardiac monitoring companies, device manufacturers, hospitals and independent diagnostic testing facilities.
Source: AI Health Index, September 2026
Eko Health makes digital stethoscopes and FDA-cleared software that analyzes heart sounds and a single-lead ECG recorded during a routine exam. The models flag structural heart murmurs in adults and children, atrial fibrillation in adults, and low ejection fraction (40 percent or below) in adults at risk of heart failure.
Source: AI Health Index, September 2026
Questions buyers ask
How are AccurKardia and Eko Health priced and sold?
For AccurKardia, the company sells interpretation software to cardiac monitoring companies, device manufacturers, hospitals and independent diagnostic testing facilities, and describes version 2.0 as built to process high volume ECG streams at lower cost; its site links terms of use.
With Eko Health, the plan comparison lists a free Eko Standard tier, Eko+ at $119.99 a year per clinician with murmur and atrial fibrillation detection, and a veterinary tier at $180, all bought online; the CORE 500 stethoscope is sold in the store at $449 to $499. SENSORA, which adds low ejection fraction detection, administration, EHR work and on-site training, is an annual enterprise license priced through sales. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
How do AccurKardia and Eko Health handle patient data?
In AccurKardia's case, the data path crosses several organizations. The platform is cloud based and ingests recordings made on other companies' patches and Holter monitors, returning interpretations to monitoring services, hospitals and diagnostic testing facilities, so one recording can pass through a device maker, a monitoring service, this interpretation layer and a reading facility, each with its own terms.
For Eko Health, the enterprise terms and conditions give Eko a perpetual, irrevocable, royalty-free license to use customer data in de-identified or aggregated form for any purpose, naming the development of its algorithms, and assign it all rights in aggregated statistics. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
Which settings and specialties do AccurKardia and Eko Health cover?
With AccurKardia, the version 2.0 indication covers adults 22 and older prescribed outpatient cardiac monitoring for up to ten days, single lead recordings from wet silver chloride electrodes, assessed by qualified healthcare professionals in office or clinical settings, across 13 rhythm classifications, which is narrow and supported by FDA review.
In Eko Health's case, the clinical scope is cardiac detection: structural murmur for adults and children, atrial fibrillation for adults, and low ejection fraction for adults at risk of heart failure, with capture by medical assistants and nurses at intake. Primary care is validated in the UK trial and the prospective US valve study, and each cleared model has its own validation population. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Both records were reviewed on this site in September 2026. Eko publishes its clinician price; AccurKardia does not publish one. Eko's software works only with Eko hardware.
Ask both how their detection performs in the patients you see most, and how a flagged result reaches the clinician who acts on it.